logo
Plus   Neg
Share
Email

ABIOMED Inc. (ABMD) Surged To A New High After Q4 Report

ABIOMED Inc. (ABMD) reported fourth quarter GAAP EPS of $0.80 Thursday morning, compared to $0.33 in the previous year. Revenues increased 40 percent to $174.4 million. The company expects to report full year 2019 revenues of $740 million to $770 million.

ABIOMED gapped up slightly Thursday and spiked higher in early trade. The stock settled into a range for the bulk of the session and closed up by 33.43 at $335.57 on the highest volume of the year. ABIOMED surged to a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT
>